Main Article Content
Purpose: To investigate the safety and efficacy of high-frequency deep sclerotomy combined with phacoemulsification in open-angle glaucoma patients with concomitant cataracts.
Materials and methods: Nine patients (mean age = 77 years) underwent combined high-frequency deep sclerotomy with phacoemulsification. The main outcome measures were intraocular pressure and the number of ocular hypotensive eyedrops. The results are presented as arithmetic means and standard deviations. The data were analyzed using Student’s t-test. Values of p < 0.05 were considered statistically significant.
Results: Mean preoperative intraocular pressure was 23.56 ± 2.7 mmHg. After 6 months, the follow-up average intraocular pressure was 16.89 ± 1.54 mmHg. Four patients did not require any topical glaucoma medication until their last follow-up. Five patients were able to reduce the number of intraocular pressure-lowering medications. The number of glaucoma medications was 2.44 ± 0.53 and 0.67 ± 0.71 before and after surgery, respectively. No serious complications were observed during the surgical procedure itself or in the postoperative period, with the exception of mild intraoperative hyphema.
Conclusion: Intraocular pressure after surgery was significantly lower than at baseline. A substantial proportion of patients was able to discontinue or reduce intraocular pressure-lowering medications. High-frequency deep sclerotomy combined with cataract surgery is a safe and effective minimally invasive procedure for the treatment of open-angle glaucoma.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright: © Medical Education sp. z o.o. License allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (email@example.com)
2. Saheb H, Ahmed II. Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol. 2012; 23: 96-104.
3. Marchini G, Ceruti P, Vizzari G. Management of concomitant cataract and glaucoma. Dev Ophthalmol. 2012; 50: 146-56.
4. Jurowski P, Goś R. Fakosklerotalamotomia – nowa metoda chirurgicznego leczenia współistniejącej zaćmy i jaskry. Istota techniki operacyjnej. Klin Oczna. 2007; 109: 276-9.
5. Fine IH, Mojon DS. Minimally invasive ophthalmic surgery. Springer, Berlin 2010: 161-96.
6. Pajic B, Cvejic Z, Mansouri K et al. High-Frequency Deep Sclerotomy, A Minimal Invasive Ab Interno Glaucoma Procedure Combined with Cataract Surgery: Physical Properties and Clinical Outcome. Appl Sci. 2020; 10: 218.
7. Pajic B, Pajic-Eggspuehler B, Haefliger I. New minimally invasive, deep sclerotomy ab interno surgical procedure for glaucoma, six years of follow-up. J Glaucoma. 2011; 20: 109-14.
8. Abushanab MMI, El-Shiaty A, El-Beltagi T et al. The Efficacy and Safety of High-Frequency Deep Sclerotomy in Treatment of Chronic Open-Angle Glaucoma Patients. BioMed Res Int. 2019; 2019: 1850141.
9. Baudouin C. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma. Acta Ophthalmol. 2008; 86(7): 716-26.
10. Broadway DC, Grierson I, O’Brien C et al. Adverse effects of topical antiglaucoma medication regimens. Effect on the cell profile of the conjunctiva. Arch Ophthalmol. 1994; 112: 1437-45.